The company operates as a holding company, currently investing in a pharmacy business that sells pharmaceuticals, cosmetics, dietary supplements, medical equipment, and various health products. It also engages in research and development with external research teams and outsources manufacturing to distribute health products and innovations.
| 3M25 | 3M24 | 2024 | 2023 |
|---|
| Revenues | 578.57 | 494.82 | 2,017.89 | 1,659.31 |
| Expenses | 550.62 | 470.79 | 1,916.05 | 1,558.59 |
| Net Profit (Loss) | 20.46 | 18.58 | 78.26 | 74.68 |
| Assets | 1,551.78 | 1,432.08 | 1,499.06 | 1,382.35 |
| Liabilities | 525.50 | 445.45 | 493.23 | 414.29 |
| Shareholders' Equity | 1,026.28 | 986.63 | 1,005.82 | 968.05 |
| Operating | 47.01 | 32.86 | 88.76 | 91.26 |
| Investing | -46.66 | 22.13 | -171.89 | 177.28 |
| Financing | -12.54 | -9.33 | -83.01 | -80.08 |
| EPS (Baht) | 0.08 | 0.07 | 0.29 | 0.27 |
| GP Margin (%) | 23.16 | 21.73 | 23.51 | 23.06 |
| NP Margin (%) | 3.54 | 3.75 | 3.88 | 4.50 |
| D/E Ratio (x) | 0.51 | 0.45 | 0.49 | 0.43 |
| ROE (%) | 7.96 | 8.29 | 7.93 | 7.82 |
| ROA (%) | 7.10 | 7.76 | 7.08 | 7.50 |
The company group has continuous branch expansion plans, focusing on the Bangkok metropolitan area and surrounding provinces due to their high market value. There is a plan to open 14 branches in 2025. In addition, the company group plans to add new innovative product items under its own brand and expand distribution channels outside the company network.
- Adheres to a policy of conducting business with fairness, respect for the law, and transparency.
- Committed to strictly complying with regulations and laws.
- Complies with international labor laws and regulations, as well as fundamental human rights.
- Prioritizes customer responsibility by selecting quality products and services, providing accurate and up-to-date information to customers, and maintaining customer confidentiality.
- Has a policy of promoting environmental care by reducing the use of plastic bags and cardboard boxes, implementing an ERP system to reduce paper usage, and piloting the use of the e-Tax system with capable partners.
- Recognizes the importance of strong communities and sustainable social development by participating in and promoting various activities in public health, education, and Buddhism.
- Participates in the "Pharmaceutical Blister Pack Recycling Program" to promote sustainable waste management. The group's pharmacies serve as collection points for foil blister packs, which are then processed to create value and benefit from waste.
- Collaborates with iRedcross on the "Parkinson's Support Project" to support the identification and care of Parkinson's patients, helping them receive appropriate care and improve their quality of life.
Invests in pharmaceutical retail and research and development businesses in collaboration with external research teams to distribute innovative health products. Owns four pharmacy brands with 65 branches in Bangkok and surrounding areas, and three innovative product brands: "Prime" for dietary supplements, "Besuto" for health and hygiene products, and "Q" health products from herbal innovations.
In Q1/2025, the Group achieved sales revenue of THB 569.80 million, representing an 18.11% year-over-year (YOY) increase. All product categories experienced revenue growth, with the highest growth rate of 36.69% YOY from the personal healthcare segment, followed by medical food at 18.07% YOY. The Group reported other income of THB 8.77 million, marking a 47.38% YOY increase, primarily driven by the expansion in the number of branches and sales areas. In Q1/2025, the Group achieved a gross profit margin of 23.16%, up from 21.73% in Q1/2024. Net profit reached THB 20.46 million in Q1/2025, a 10.14% YOY increase from THB 18.58 million in Q1/2024. Notably, the prior-year figure included a non-recurring gain of THB 6.45 million from the disposal of non-current assets classified as held-for-sale.
- As of March 31, 2025, the Group had a total of 65 pharmacy branches in operation, with 1 new branch added in first quarter of 2025 in the Bangkok metropolitan area.
- Launched new herbal health product - “Herbal Mouth Spray Q Brand”, an herbal spray developed to help reduce viral accumulation.
- The Board of Directors’ Meeting No. 2/2025 passed a resolution for treasury stock program for financial management purpose in the amount not exceeding THB100MN. The number of ordinary shares to be repurchased is not exceeding 15,000,000 shares at a par value of Baht 0.50 per share or not exceeding 5.51 percent of total number of paid-up share capital. The Company shall repurchase its ordinary shares through the main board of the Stock Exchange of Thailand for the period of six-month from May 19, 2025 to November 18, 2025.
- Since founding the drugstore 30 years ago, the Group has sourced from two major distributors. The partnership has gone well. However, the Group has regularly reviewed new suppliers to ensure it secures sufficient products.
- In terms of competition risk, the Group focuses on expanding branches to strategic locations in Bangkok and having pharmacists stationed at all branches to guarantee superior quality of services.
- The Group is widely recognized in pharmacist professional group, as it has been offering internship programs for pharmaceutical students from leading universities for years. This has efficiently mitigated the risk of pharmacist shortage.
- Silver Medal, Innovation: Cell Matrix Technology - Prime VISION INVENTION GENEVA EVALUATION DAYS; March 28, 2022
- Gold Medal Award, Innovation: Prime MOVX2 - 2022 Japan Design, Idea & Invention Expo; July 1-3, 2022
- Gold Medal Award, Innovation: Prime KIN - 2024 Japan Design, Idea & Invention Expo; July 5-7, 2024
- Gold Medal Award, Innovation and Invention: Prime Bioenhancz - 2024 PRIX EIFFEL, Idea & Invention Expo; November 12, 2024
- Special Award, Innovation: Prime Bioenhancz - Innovation Initiative Co-operative Inc. (CANADA); November 12-13, 2024
- Silver Medal Award, Innovation and Invention: Q Herbal Mouth Spray - 2024 PRIX EIFFEL, Idea & Invention Expo; November 12-13, 2024
| as of 31/03/25 | HL | SERVICE | mai |
|---|---|---|---|
| P/E (X) | 22.42 | 54.71 | 37.47 |
| P/BV (X) | 1.74 | 1.51 | 1.22 |
| Dividend yield (%) | 2.64 | 3.60 | 3.80 |
| 31/03/25 | 30/12/24 | 28/12/23 | |
|---|---|---|---|
| Market Cap (MB) | 1,754.40 | 2,774.40 | 2,828.80 |
| Price (B/Share) | 6.45 | 10.20 | 10.40 |
| P/E (X) | 22.42 | 36.14 | 35.81 |
| P/BV (X) | 1.74 | 2.85 | 3.02 |